Legal Representation
Attorney
Brendan J. Hughes
USPTO Deadlines
Next Deadline
733 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220104)
Due Date
January 04, 2028
Grace Period Ends
July 04, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 1, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jun 20, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 20, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 20, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 20, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 1, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 30, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 30, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 24, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 24, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 17, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 16, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 9, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 16, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 9, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 6, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 6, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 6, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 6, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 29, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 27, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 27, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 27, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 5, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 3, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 3, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 3, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 11, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 17, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 17, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 27, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 7, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 4, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 4, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 4, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 4, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 4, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 31, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 31, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 30, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 28, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 6, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating viral infections and diseases; Pharmaceutical preparations for treating infections and infectious diseases; anti-infective drugs for medical purposes; therapeutic pharmaceutical formulations for treating infections and infectious diseases; anti-infectives; antivirals; pharmaceutical preparations in the nature of anti-viral therapies, namely, antivirals
First Use Anywhere:
20060700
First Use in Commerce:
20060700
Classification
International Classes
005